Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

3.53
+0.06001.73%
Post-market: 3.530.00000.00%16:20 EDT
Volume:449.80K
Turnover:1.60M
Market Cap:302.10M
PE:-2.14
High:3.62
Open:3.50
Low:3.49
Close:3.47
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 12, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 30, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 26, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 09, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 08, 2018

Major Issues Report

Mar 30, 2018

Major Issues Report

Feb 13, 2018

Beneficial Ownership Change

Feb 09, 2018

Business Combinations

Aviragen疗法公司。
Feb 09, 2018

Business Combinations

Aviragen疗法公司。